177 Preclinical characterization of CYT-100 iPSC derived NK cells alone and in combination with CYT-303 NK cell engager for hepatocellular carcinoma (HCC) | Zendy

AI Assistant Blog Pricing

177 Preclinical characterization of CYT-100 iPSC derived NK cells alone and in combination with CYT-303 NK cell engager for hepatocellular carcinoma (HCC)

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.